- Home
- WOLF vs AMPH Comparison
WOLF vs AMPH Comparison
Compare WOLF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- AMPH
- Stock Information
- Founded
- WOLF 1987
- AMPH 1996
- Country
- WOLF United States
- AMPH United States
- Employees
- WOLF N/A
- AMPH N/A
- Industry
- WOLF Semiconductors
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- WOLF Technology
- AMPH Health Care
- Exchange
- WOLF Nasdaq
- AMPH Nasdaq
- Market Cap
- WOLF 978.5M
- AMPH 1.1B
- IPO Year
- WOLF 1993
- AMPH 2014
- Fundamental
- Price
- WOLF $1.20
- AMPH $25.71
- Analyst Decision
- WOLF Hold
- AMPH Hold
- Analyst Count
- WOLF 14
- AMPH 5
- Target Price
- WOLF $10.67
- AMPH $38.00
- AVG Volume (30 Days)
- WOLF 50.0M
- AMPH 566.0K
- Earning Date
- WOLF 05-08-2025
- AMPH 05-07-2025
- Dividend Yield
- WOLF N/A
- AMPH N/A
- EPS Growth
- WOLF N/A
- AMPH N/A
- EPS
- WOLF N/A
- AMPH 2.77
- Revenue
- WOLF $761,300,000.00
- AMPH $730,659,000.00
- Revenue This Year
- WOLF N/A
- AMPH $0.65
- Revenue Next Year
- WOLF $14.89
- AMPH $5.26
- P/E Ratio
- WOLF N/A
- AMPH $9.30
- Revenue Growth
- WOLF N/A
- AMPH 8.05
- 52 Week Low
- WOLF $0.82
- AMPH $22.64
- 52 Week High
- WOLF $30.86
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- WOLF 31.84
- AMPH 56.96
- Support Level
- WOLF $1.33
- AMPH $23.74
- Resistance Level
- WOLF $1.90
- AMPH $25.72
- Average True Range (ATR)
- WOLF 0.38
- AMPH 0.73
- MACD
- WOLF -0.23
- AMPH 0.24
- Stochastic Oscillator
- WOLF 11.05
- AMPH 92.28
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.